Skip to main content

Quinidine Gluconate Injection Shortage

Last Updated: March 4, 2020
Status: Discontinued

Products Affected - Description
    • Quinidine gluconate injection, Lilly USA, LLC, 80 mg/mL, 10 mL vial, 1 count, NDC 00002-1407-01 - discontinued
Reason for the Shortage
    • Lilly USA is the sole supplier of quinidine gluconate injection and is discontinuing the manufacture of the product.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Lilly USA has stopped marketing quinidine gluconate 80 mg/mL 10 mL vials.

Implications for Patient Care

    • CDC and FDA are working to ensure adequate treatment options are available for patients.

Updated

Updated March 4, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 11, 2019 by Anthony Trovato, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer